Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1985 Mar;61(713):239–242. doi: 10.1136/pgmj.61.713.239

Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.

A B Atkinson, A L Kennedy, B Sheridan
PMCID: PMC2418213  PMID: 2984649

Abstract

A patient with ACTH-dependent Cushing's syndrome remained in clinical and biochemical remission six years after pituitary irradiation and while on bromocriptine therapy. When bromocriptine was discontinued urinary free cortisol values became elevated, and were not suppressed by dexamethasone. After reintroduction of the drug, remission was again obtained. It is concluded that bromocriptine is responsible for continuing longterm remission in this case. The possible use of bromocriptine as an adjunctive therapy in ACTH-dependent Cushing's syndrome is discussed.

Full text

PDF
239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosi B., Gaggini M., Secchi F., Faglia G. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome. Horm Metab Res. 1979 Apr;11(4):318–319. doi: 10.1055/s-0028-1095778. [DOI] [PubMed] [Google Scholar]
  2. Burch W. A survey of results with transsphenoidal surgery in Cushing's disease. N Engl J Med. 1983 Jan 13;308(2):103–104. doi: 10.1056/NEJM198301133080216. [DOI] [PubMed] [Google Scholar]
  3. Davies C., Jacobi J., Lloyd H. M., Meares J. D. DNA synthesis and the secretion of prolactin and growth hormone by the pituitary gland of the male rat: effects of diethylstilboestrol and 2-bromo-alpha-ergocryptine methanesluphonate. J Endocrinol. 1974 Jun;61(3):411–417. doi: 10.1677/joe.0.0610411. [DOI] [PubMed] [Google Scholar]
  4. Hayslett J. P., Cohn G. L. Spontaneous remission of Cushing's disease. Report of a case. N Engl J Med. 1967 Apr 27;276(17):968–970. doi: 10.1056/NEJM196704272761708. [DOI] [PubMed] [Google Scholar]
  5. Kapcala L. P., Jackson I. M. Long term bromocriptine therapy in Cushing's disease. J Endocrinol Invest. 1982 Mar-Apr;5(2):117–120. doi: 10.1007/BF03350502. [DOI] [PubMed] [Google Scholar]
  6. Kennedy A. L., Sheridan B., Montgomery D. A. ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease. Acta Endocrinol (Copenh) 1978 Nov;89(3):461–468. doi: 10.1530/acta.0.0890461. [DOI] [PubMed] [Google Scholar]
  7. Krieger D. T., Amorosa L., Linick F. Cyproheptadine-induced remission of Cushing's disease. N Engl J Med. 1975 Oct 30;293(18):893–896. doi: 10.1056/NEJM197510302931802. [DOI] [PubMed] [Google Scholar]
  8. Lamberts S. W., Birkenhäger J. C. Effect of bromocriptine in pituitary-dependent Cushing's syndrome. J Endocrinol. 1976 Aug;70(2):315–316. doi: 10.1677/joe.0.0700315. [DOI] [PubMed] [Google Scholar]
  9. Lamberts S. W., Klijn J. G., de Quijada M., Timmermans H. A., Uitterlinden P., de Jong F. H., Birkenhäger J. C. The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome. J Clin Endocrinol Metab. 1980 Aug;51(2):307–311. doi: 10.1210/jcem-51-2-307. [DOI] [PubMed] [Google Scholar]
  10. Lamberts S. W., Timmermans H. A., De Jong F. H., Birkenhager J. C. The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences for medical therapy. Clin Endocrinol (Oxf) 1977 Sep;7(3):185–193. doi: 10.1111/j.1365-2265.1977.tb01314.x. [DOI] [PubMed] [Google Scholar]
  11. Lamberts S. W., de Lange S. A., Stefanko S. Z. Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion. J Clin Endocrinol Metab. 1982 Feb;54(2):286–291. doi: 10.1210/jcem-54-2-286. [DOI] [PubMed] [Google Scholar]
  12. Lloyd H. M., Meares J. D., Jacobi J. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells. Nature. 1975 Jun 5;255(5508):497–498. doi: 10.1038/255497a0. [DOI] [PubMed] [Google Scholar]
  13. Pieters G. F., Smals A. G., Goverde H. J., Pesman G. J., Meyer E., Kloppenborg P. W. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease. J Clin Endocrinol Metab. 1982 Dec;55(6):1188–1197. doi: 10.1210/jcem-55-6-1188. [DOI] [PubMed] [Google Scholar]
  14. Riad-Fahmy D., Read G. F., Gaskell S. J., Dyas J., Hindawi R. A simple, direct radioimmunoassay for plasma cortisol, featuring a 125I radioligand and a solid-phase separation technique. Clin Chem. 1979 May;25(5):665–668. [PubMed] [Google Scholar]
  15. Spark R. F., Dickstein G. Bromocriptine and endocrine disorders. Ann Intern Med. 1979 Jun;90(6):949–956. doi: 10.7326/0003-4819-90-6-949. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES